Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hinrichsen, Inga ^a   Kemp, Matthias ^a   Peveling Oberhag, Jan ^a   Passmann, Sandra ^a   Plotz, Guido ^a   Zeuzem, Stefan ^a   Brieger, Angela ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2;

ADULT; ADVANCED CANCER; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; DNA ISOLATION; DNA METHYLATION; FEMALE; GENE SILENCING; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; PROMOTER REGION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM GRADING; NEOPLASM STAGING; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC;

EID: 84897005802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084453     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Wang XW, Hussain SP, Huo TI, Wu CG, Forgues M, et al. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 181-182: 43-47. (Pubitemid 36015671)
3. Moradpour D, Blum HE (2000) [Molecular aspects of hepatocellular carcinoma]. Zentralbl Chir 125: 592-596.
4. Feitelson MA (2006) Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett 239: 10-20. (Pubitemid 43949592)
5. Kondoh N, Wakatsuki T, Hada A, Shuda M, Tanaka K, et al. (2001) Genetic and epigenetic events in human hepatocarcinogenesis. Int J Oncol 18: 1271-1278.
6. Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, et al. (2008) Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 47: 908-918. (Pubitemid 351449682)
7. Feng Q, Stern JE, Hawes SE, Lu H, Jiang M, et al. (2010) DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. Exp Mol Pathol 88: 287-292.
8. Matsukura S, Soejima H, Nakagawachi T, Yakushiji H, Ogawa A, et al. (2003) CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. Br J Cancer 88: 521-529. (Pubitemid 36363361)
9. Abdel-Rahman N, Zekri AAB, Abdalah S, Saleh M, El-Sherif GM, et al. (2001) Mismatch Repair and Multi-Drug Resistance Genes Expression in Relation to HCV-Associated Hepatocellular Carcinoma. Journal of Egyptian Nat Cancer Inst 13: 129-138.
10. Lim JS, Park SH, Jang KL (2012) Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation. Cancer Lett 321: 154-161.
11. Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, et al. (2012) Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors. Hepatology 56: 1817-1827.
12. Deng YB, Nagae G, Midorikawa Y, Yagi K, Tsutsumi S, et al. (2010) Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma. Cancer Sci 101: 1501-1510.
13. Li Z, Zhang H, Yang J, Hao T, Li S (2012) Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Cell Biol Int 36: 427-432.
14. Wang L, Bani-Hani A, Montoya DP, Roche PC, Thibodeau SN, et al. (2001) hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol 19: 567-570.
15. Ahmed R, Salama H, Fouad A, Sabry D, AbdAlah el S, et al. (2010) Detection of aberrant p16INK4A methylation in sera of patients with HCV-related liver diseases: An Egyptian study. Med Sci Monit 16: CR410-415.
16. Kaneto H, Sasaki S, Yamamoto H, Itoh F, Toyota M, et al. (2001) Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut 48: 372-377. (Pubitemid 32269566)
17. Ishak KG AP, Sobin LH (1994) Histological typing of tumours in the liver (International histological classification of tumours 2nd ed). Berlin: Springer-Verlag.
18. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, et al. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550.
19. Liu B, Parsons RE, Hamilton SR, Petersen GM, Lynch HT, et al. (1994) hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54: 4590-4594. (Pubitemid 24276477)
20. Pedroni M, Roncari B, Maffei S, Losi L, Scarselli A, et al. (2007) A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. Dis Markers 23: 179-187. (Pubitemid 46868409)
21. Zhang CJ, Li HM, Yau LM, Suen KW, Zhou GY, et al. (2004) [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma]. Zhonghua Bing Li Xue Za Zhi 33: 433-436.
22. Helal TE, Khamis NS, El-Sharkawy TM, Nada OH, Radwan NA (2010) Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt. APMIS 118: 934-940.
23. Wani Y, Notohara K, Tsukayama C, Okada S (2001) Reduced expression of hMLH1 and hMSH2 gene products in high-grade hepatocellular carcinoma. Acta Med Okayama 55: 65-71. (Pubitemid 33605240)
24. Zekri AR, Sabry GM, Bahnassy AA, Shalaby KA, Abdel-Wahabh SA, et al. (2005) Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma. World J Gastroenterol 11: 3020-3026. (Pubitemid 40790656)
25. Arora P, Kim EO, Jung JK, Jang KL (2008) Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett 261: 244-252.
26. Benegiamo G, Vinciguerra M, Mazzoccoli G, Piepoli A, Andriulli A, et al. (2012) DNA methyltransferases 1 and 3b expression in Huh-7 cells expressing HCV core protein of different genotypes. Dig Dis Sci 57: 1598-1603.
27. Fang JY, Lu R, Mikovits JA, Cheng ZH, Zhu HY, et al. (2006) Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Cancer Lett 233: 124-130. (Pubitemid 43214570)
28. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, et al. (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20: 1527-1536. (Pubitemid 34260532)